Archived Webinars

Learn about applications of the latest technologies and strategies to achieve successful commercialization from AABME's Access to SMEs webinar series.

Free Content

Computational Fluid Dynamics and Multiphysics Cardiac Simulations Based on Medical Imaging and Electromechanical Models

To fully understand cardiac function, it’s necessary to go beyond modeling the structure of the heart, and look at the detailed behavior of blood as it interacts with that structure. This can be accomplished by using a technology borrowed from aerospace and automotive engineering: Computational Fluid Dynamics (CFD) simulation.

Avoiding Common Pitfalls in Product Development (including customer need)

A great idea doesn't always translate to a successful product. In this webinar, hear from Tiffany Wilson, who has spent years advancing innovative medical technology from benchtop to bedside, as she share the common pitfalls in product development.

Hot Topics in Genome Editing: TALEN/CRISPR/ZFN

Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. View this recorded webinar, moderated by Gang Bao, and understand the differences between three technologies.

Commercialization in Bioengineering: Starting with the Need and Not the Technology

Traditionally, innovation has started with technology looking for a need. However, the complexities and variety of stakeholders involved in commercialization in biomedical technology call for a different approach - to lead with the need.

Translation of Bio-Inspired Materials Towards Biomedical and Clinical Applications

Markus J. Buehler, PhD, McAfee Professor of Engineering, MIT, unravels how materiomics – the study of bio-inspired materials and design – is creating a roadmap for the treatment of disease.

Getting to Know Your Digital Twin

Marc Horner, Ph.D., Technical Lead, Healthcare at ANSYS, Inc. explains the concept of the digital twin and computational modeling as a critical element of modern healthcare.

Conducting Effective FDA Pre-Sub Meetings: Tell, Don’t Ask… Lead, Don’t Follow!

For medical device companies, ineffective communication with FDA often leads to time-consuming and costly delays. Manufacturers may assume a classification or regulatory pathway for a new device – only to learn later that FDA disagrees. Unfortunately, most of these delays are completely avoidable!